Sureau P, Rollin P, Lafon M
Dev Biol Stand. 1984;57:227-31.
A group of WHO Consultants who met in Geneva 16-18 September 1982, recommended, among other items, that "monoclonal antibody reactivity pattern of all viruses used for (rabies) vaccine production should be established" (WHO/Rab.Res./82.15) (1). Such a study has been undertaken in our WHO Collaborative Centre for Rabies in close collaboration with the WHO Collaborative Centre for Rabies of the Wistar Institute, and with monoclonal antibodies kindly supplied by T.J. Wiktor (2).
1982年9月16日至18日在日内瓦召开会议的一组世界卫生组织顾问建议,除其他事项外,“应确定用于(狂犬病)疫苗生产的所有病毒的单克隆抗体反应模式”(WHO/Rab.Res./82.15)(1)。我们的世界卫生组织狂犬病合作中心与维斯塔研究所世界卫生组织狂犬病合作中心密切合作,并在T.J.维克托好心提供的单克隆抗体的帮助下,开展了这样一项研究(2)。